Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Salmon
    Junior Member
    • Jan 2009
    • 9

    454 sequencing data coverage

    Dear All,

    I am currently working on 454 sequencing data. The average length of reads is ~200bp, and coverage is ~8-10X.

    Does anybody tell me how the data coverage is? Is it ok or not?
    Because when I do annotation, I found many many single nucleotide changes (mutation/insertion/deletion).

    Thank you.
  • sklages
    Senior Member
    • May 2008
    • 628

    #2
    de-novo or refguided?

    We usually work with ~30x coverage when dealing with both denovo and refguided assemblies (FLX), Though you might need a bit less for refguided. This is for bacterial genome size projects (1-8Mb) here.

    Sven

    Comment

    • hlu
      Member
      • Jan 2009
      • 32

      #3
      We usually do 20x de novo assembly. This works for either FLX or Titanium.

      Sounds that you are still doing FLX.

      454 Titanium paired end data improved a lot compared to FLX paired end. Now I would think perferrably, 10x shot gun, and 10x paired end.

      Recently I did a de novo assembly on a , 454 machine can run 2 pads in same runs. 1 pad for shot gun, another pad for paired end data in same run. The fungi assembly worked well for us.
      Last edited by hlu; 02-05-2009, 02:23 PM.

      Comment

      • kmcarr
        Senior Member
        • May 2008
        • 1181

        #4
        Originally posted by hlu View Post
        454 Titanium paired end data improved a lot over compared to FLX paired end.
        hlu,

        I don't think the Titanium paired end kits are available yet. Are you doing a home brew paired end with Titanium?

        Comment

        • hlu
          Member
          • Jan 2009
          • 32

          #5
          Originally posted by kmcarr View Post
          hlu,

          I don't think the Titanium paired end kits are available yet. Are you doing a home brew paired end with Titanium?
          I am using early access 454 Titanium pairs end kits.

          There are not out there yet public. I heard from 454 sales that they will be out possibly within a month. So it will be there soon.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...